Abstract
The first generation of in silico hERG models have focused on key driving forces for hERG/ligand binding: basicity and lipophilicity. While reducing basicity and lipophilicity are typically the first line approaches to eliminating hERG blocking activity, in many programs these are not feasible approaches because basicity and lipophilicity are frequently necessary for achieving good pharmacokinetics or primary target binding. Thus for the second, generation of in silico hERG models, a focus on understanding the more subtle aspects of hERG binding is necessary. Thus, the focus of this review is on extracting ideas, either qualitative or quantitative, from the various modeling efforts as to how hERG activity might be eliminated or diminished beyond simply reducing basicity and lipophilicity. In addition, several areas where key questions around hERG binding have not been adequately addressed by in silico work are highlighted.
Current Computer-Aided Drug Design
Title: In Silico hERG Modeling: Challenges and Progress
Volume: 5 Issue: 2
Author(s): David J. Diller
Affiliation:
Abstract: The first generation of in silico hERG models have focused on key driving forces for hERG/ligand binding: basicity and lipophilicity. While reducing basicity and lipophilicity are typically the first line approaches to eliminating hERG blocking activity, in many programs these are not feasible approaches because basicity and lipophilicity are frequently necessary for achieving good pharmacokinetics or primary target binding. Thus for the second, generation of in silico hERG models, a focus on understanding the more subtle aspects of hERG binding is necessary. Thus, the focus of this review is on extracting ideas, either qualitative or quantitative, from the various modeling efforts as to how hERG activity might be eliminated or diminished beyond simply reducing basicity and lipophilicity. In addition, several areas where key questions around hERG binding have not been adequately addressed by in silico work are highlighted.
Export Options
About this article
Cite this article as:
Diller J. David, In Silico hERG Modeling: Challenges and Progress, Current Computer-Aided Drug Design 2009; 5 (2) . https://dx.doi.org/10.2174/157340909788451928
DOI https://dx.doi.org/10.2174/157340909788451928 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Combining Diffusion-Weighted Imaging Patterns with ABCD2 Score Predicts Stroke Risk after Transient Ischemic Attack
Current Neurovascular Research Mechanisms Linking Leptin to Arterial and Venous Thrombosis: Potential Pharmacological Targets
Current Pharmaceutical Design Isolated Perioperative Hypertension: Clinical Implications & Contemporary Treatment Strategies
Current Hypertension Reviews Oxidative stress and myocarditis
Current Pharmaceutical Design Natural Antioxidants in Wheat Sprout Extracts
Current Organic Chemistry Recent Drug Development Approaches in Thrombosis, Stroke and other Cardiovascular Diseases
Current Pharmaceutical Design Modulation of Platelet Function and Signaling by Flavonoids
Mini-Reviews in Medicinal Chemistry Coronary Pressure Measurement Based Decision Making for Percutaneous Coronary Intervention
Current Cardiology Reviews Microvascular Function/Dysfunction Downstream a Coronary Stenosis
Current Pharmaceutical Design WITHDRAWN: Current Trends in the Detection of Biological Proteins and Immunological Assays using Graphene Quantum Dots
Current Analytical Chemistry Anaemia, Polycythaemia and Chronic Heart Failure
Current Cardiology Reviews The Hydroxamic Acids as Potential Anticancer and Neuroprotective Agents
Current Medicinal Chemistry A Novel Finding: Macrophages Involved in Inflammation Participate in Acute Aortic Dissection Complicated with Acute Lung Injury
Current Molecular Medicine Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia
Current Pharmaceutical Design Pulmonary Hypertension: Role of Combination Therapy
Current Vascular Pharmacology Retracted: Potential Health Benefits of Broccoli- A Chemico-Biological Overview
Mini-Reviews in Medicinal Chemistry Vascular microRNAs
Current Drug Targets Maternal Nutrition and Predisposition to Later Kidney Disease
Current Drug Targets Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation
Medicinal Chemistry Interaction of Anthocyanins with Drug-metabolizing and Antioxidant Enzymes
Current Medicinal Chemistry